Broncochem Syrup
NDC Package 65131-116-87

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Broncochem (acetaminophen-chlorpheniramine maleate-dextromethorphan hbr-guaifenesin-phenylephrine hcl) syrups is bronchial congestionIrritation of the respiratory passagesNasal congestionHelps loosen phlegm (mucus) and dilute bronchial secretions to make coughs more productiveAntitussiveTemporarilly relieves allergy symptoms including runny nose, sneezing, stuffy nose, itchy nose, itchy throat, irritated and watery eyes, allergic rhinitis. This formulation utilizes a syrup delivery system. Marketed by Laboratorio Magnachem International Srl, this product is identified by NDC 65131-116 and is authorized under FDA application part343.

Identification & Billing

NDC Package Code
65131-116-87
Package Description
1 BOTTLE, PLASTIC in 1 BOX / 120 mL in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
65131011687
RxNorm Crosswalk
  • RxCUI: 1743369 - acetaminophen 250 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 13.33 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG in 10 mL Oral Solution
  • RxCUI: 1743369 - acetaminophen 25 MG/ML / chlorpheniramine maleate 0.4 MG/ML / dextromethorphan hydrobromide 1.33 MG/ML / guaifenesin 20 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution
  • RxCUI: 1743369 - acetaminophen 250 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 13.33 MG / guaifenesin 200 MG / phenylephrine HCl 5 MG per 10 ML Oral Solution
  • RxCUI: 1743369 - APAP 25 MG/ML / Chlorpheniramine Maleate 0.4 MG/ML / Dextromethorphan Hydrobromide 1.33 MG/ML / Guaifenesin 20 MG/ML / Phenylephrine Hydrochloride 0.5 MG/ML Oral Solution

Clinical Specifications

Proprietary Name
Broncochem Expectorant Ii
Non-Proprietary Name
Acetaminophen-chlorpheniramine Maleate-dextromethorphan Hbr-guaifenesin-phenylephrine Hcl
Substance Name
Acetaminophen; Chlorpheniramine Maleate; Dextromethorphan Hydrobromide; Guaifenesin; Phenylephrine Hydrochloride
Dosage Form
Syrup - An oral solution containing high concentrations of sucrose or other sugars; the term has also been used to include any other liquid dosage form prepared in a sweet and viscid vehicle, including oral suspensions.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
Bronchial congestionIrritation of the respiratory passagesNasal congestionHelps loosen phlegm (mucus) and dilute bronchial secretions to make coughs more productiveAntitussiveTemporarilly relieves allergy symptoms including runny nose, sneezing, stuffy nose, itchy nose, itchy throat, irritated and watery eyes, allergic rhinitis

Regulatory & Marketing

Labeler Name
Laboratorio Magnachem International Srl
Product Type
Human Otc Drug
FDA Application #
part343
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
12-30-2016
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 65131-116-87 identifies a specific commercial package of 1 bottle, plastic in 1 box / 120 ml in 1 bottle, plastic of Broncochem Expectorant Ii, a human over the counter drug labeled by Laboratorio Magnachem International Srl. This syrup is formulated for oral use and contains acetaminophen; chlorpheniramine maleate; dextromethorphan hydrobromide; guaifenesin; phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Laboratorio Magnachem International Srl on December 30, 2016. The current certification is valid through December 31, 2026.

How is this Laboratorio Magnachem International Srl product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 65131011687. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
65131-116-87
11-Digit CMS (5-4-2)
65131-0116-87

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.